Telesis Bio, Inc.
TBIO
$0.30
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.57M | 1.55M | 2.19M | 6.98M | 4.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.57M | 1.55M | 2.19M | 6.98M | 4.10M |
| Cost of Revenue | 557.00K | 2.35M | 1.08M | 2.23M | 1.56M |
| Gross Profit | 1.01M | -799.00K | 1.11M | 4.75M | 2.54M |
| SG&A Expenses | 3.98M | 7.21M | 6.54M | 7.17M | 8.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.71M | 12.02M | 9.98M | 13.07M | 13.48M |
| Operating Income | -5.14M | -10.47M | -7.79M | -6.09M | -9.38M |
| Income Before Tax | -6.18M | -11.56M | -7.91M | -17.68M | -9.89M |
| Income Tax Expenses | 1.00K | 1.00K | 2.00K | 3.00K | 14.00K |
| Earnings from Continuing Operations | -6.18M | -11.56M | -7.91M | -17.69M | -9.91M |
| Earnings from Discontinued Operations | -460.00K | -1.02M | -727.00K | -- | -726.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.64M | -12.59M | -8.64M | -17.69M | -10.63M |
| EBIT | -5.14M | -10.47M | -7.79M | -6.09M | -9.38M |
| EBITDA | -4.68M | -10.05M | -7.16M | -5.44M | -8.88M |
| EPS Basic | -4.09 | -7.62 | -5.52 | -10.96 | -6.73 |
| Normalized Basic EPS | -1.89 | -3.81 | -2.90 | -2.31 | -3.72 |
| EPS Diluted | -4.09 | -7.62 | -5.52 | -10.96 | -6.73 |
| Normalized Diluted EPS | -1.89 | -3.81 | -2.90 | -2.31 | -3.72 |
| Average Basic Shares Outstanding | 1.77M | 1.73M | 1.67M | 1.67M | 1.66M |
| Average Diluted Shares Outstanding | 1.77M | 1.73M | 1.67M | 1.67M | 1.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
